Report Detail

Other Global Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2020-2026

  • RnM4271896
  • |
  • 27 December, 2020
  • |
  • Global
  • |
  • 129 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Infection Type
    • 1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Infection Type: 2020 VS 2026
    • 1.3.2 Urinary Tract Infections
    • 1.3.3 Surgical Site Infections
    • 1.3.4 Hospital-acquired Pneumonia
    • 1.3.5 BloodStream Infections
    • 1.3.6 Gastrointestinal Infections
  • 1.4 Market by Application
    • 1.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2020 VS 2026
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 ASCs
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2015-2026)
  • 2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Regions
    • 2.2.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Healthcare-associated Infectious Disease Diagnostics Industry Dynamic
    • 2.3.1 Healthcare-associated Infectious Disease Diagnostics Market Trends
    • 2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
    • 2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
    • 2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Market Size
    • 3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
  • 3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
    • 3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2019
  • 3.5 Key Players Healthcare-associated Infectious Disease Diagnostics Area Served
  • 3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
  • 3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Infection Type

  • 4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Infection Type (2015-2020)
  • 4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Infection Type (2021-2026)

5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application

  • 5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2015-2020)
  • 5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
  • 6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
  • 6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
  • 6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
  • 7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
  • 7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
  • 7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
  • 8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
  • 8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
  • 9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Infection Type (2015-2020)
  • 9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
  • 9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2015-2026)
  • 10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Abbott
    • 11.1.1 Abbott Company Details
    • 11.1.2 Abbott Business Overview
    • 11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020))
    • 11.1.5 Abbott Recent Development
  • 11.2 Accelerate Diagnostics
    • 11.2.1 Accelerate Diagnostics Company Details
    • 11.2.2 Accelerate Diagnostics Business Overview
    • 11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 11.2.5 Accelerate Diagnostics Recent Development
  • 11.3 BD
    • 11.3.1 BD Company Details
    • 11.3.2 BD Business Overview
    • 11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 11.3.5 BD Recent Development
  • 11.4 bioMrieux
    • 11.4.1 bioMrieux Company Details
    • 11.4.2 bioMrieux Business Overview
    • 11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 11.4.5 bioMrieux Recent Development
  • 11.5 Bio-Rad
    • 11.5.1 Bio-Rad Company Details
    • 11.5.2 Bio-Rad Business Overview
    • 11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 11.5.5 Bio-Rad Recent Development
  • 11.6 DiaSorin Molecular
    • 11.6.1 DiaSorin Molecular Company Details
    • 11.6.2 DiaSorin Molecular Business Overview
    • 11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 11.6.5 DiaSorin Molecular Recent Development
  • 11.7 F. Hoffmann-La Roche
    • 11.7.1 F. Hoffmann-La Roche Company Details
    • 11.7.2 F. Hoffmann-La Roche Business Overview
    • 11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 11.7.5 F. Hoffmann-La Roche Recent Development
  • 11.8 Luminex
    • 11.8.1 Luminex Company Details
    • 11.8.2 Luminex Business Overview
    • 11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 11.8.5 Luminex Recent Development
  • 11.9 Meridian Bioscience
    • 11.9.1 Meridian Bioscience Company Details
    • 11.9.2 Meridian Bioscience Business Overview
    • 11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 11.9.5 Meridian Bioscience Recent Development
  • 11.10 OpGen
    • 11.10.1 OpGen Company Details
    • 11.10.2 OpGen Business Overview
    • 11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
    • 11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 11.10.5 OpGen Recent Development
  • 11.11 QIAGEN
    • 10.11.1 QIAGEN Company Details
    • 10.11.2 QIAGEN Business Overview
    • 10.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
    • 10.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 10.11.5 QIAGEN Recent Development
  • 11.12 Quidel
    • 10.12.1 Quidel Company Details
    • 10.12.2 Quidel Business Overview
    • 10.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
    • 10.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 10.12.5 Quidel Recent Development
  • 11.13 Thermo Fisher Scientific
    • 10.13.1 Thermo Fisher Scientific Company Details
    • 10.13.2 Thermo Fisher Scientific Business Overview
    • 10.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
    • 10.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 10.13.5 Thermo Fisher Scientific Recent Development
  • 11.14 Trinity Biotech
    • 10.14.1 Trinity Biotech Company Details
    • 10.14.2 Trinity Biotech Business Overview
    • 10.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
    • 10.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 10.14.5 Trinity Biotech Recent Development
  • 11.15 Danaher
    • 10.15.1 Danaher Company Details
    • 10.15.2 Danaher Business Overview
    • 10.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
    • 10.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2015-2020)
    • 10.15.5 Danaher Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Healthcare-associated Infectious Disease Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Healthcare-associated Infectious Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Infection Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Infection Type, the product can be split into
    Urinary Tract Infections
    Surgical Site Infections
    Hospital-acquired Pneumonia
    BloodStream Infections
    Gastrointestinal Infections

    Market segment by Application, split into
    Hospitals
    Clinics
    ASCs

    Based on regional and country-level analysis, the Healthcare-associated Infectious Disease Diagnostics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Healthcare-associated Infectious Disease Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott
    Accelerate Diagnostics
    BD
    bioMrieux
    Bio-Rad
    DiaSorin Molecular
    F. Hoffmann-La Roche
    Luminex
    Meridian Bioscience
    OpGen
    QIAGEN
    Quidel
    Thermo Fisher Scientific
    Trinity Biotech


    Summary:
    Get latest Market Research Reports on Healthcare-associated Infectious Disease Diagnostics. Industry analysis & Market Report on Healthcare-associated Infectious Disease Diagnostics is a syndicated market report, published as Global Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Healthcare-associated Infectious Disease Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,844.67
    4,267.01
    5,689.34
    3,216.61
    4,824.92
    6,433.23
    405,580.50
    608,370.75
    811,161.00
    284,636.04
    426,954.06
    569,272.08
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report